FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090266 [Registered on: 07/07/2025] Trial Registered Prospectively
Last Modified On: 06/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral
Other (Specify) [MULTIMODAL ]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of multidisciplinary programme on chronic pelvic pain 
Scientific Title of Study   Multidisciplinary programme of care for women with endometriosis and its effect on chronic pelvic pain and quality of life-A Randomised control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amrita Gaurav 
Designation  Additional Professor 
Affiliation  Department of Obstetrics and Gynaecology 
Address  Department of Obstetrics and Gynecology All India institute of medical sciences, Rishikesh, Veerbhadra Marg, Pashulok Uttarakhand-249201

Dehradun
UTTARANCHAL
249201
India 
Phone  8171025511  
Fax    
Email  aamrity@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amrita Gaurav 
Designation  Additional Professor 
Affiliation  Department of Obstetrics and Gynaecology 
Address  Department of Obstetrics and Gynaecology All India institute of medical sciences, Rishikesh, Veerbhadra Marg, Pashulok-249201

Dehradun
UTTARANCHAL
249201
India 
Phone  8171025511  
Fax    
Email  aamrity@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amrita Gaurav 
Designation  Additional Professor 
Affiliation  Department of Obstetrics and Gynaecology 
Address  Department of Obstetrics and gynaecology, All India institute of medical sciences, Rishikesh, Veerbhadra Marg, pashulok- 249201

Dehradun
UTTARANCHAL
249201
India 
Phone  8171025511  
Fax    
Email  aamrity@gmail.com  
 
Source of Monetary or Material Support  
Indian Council of medical research 
 
Primary Sponsor  
Name  ICMR 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India Ph: 91-11-26588895 / 91-11-26588980, 91-11-26589794 / 91-11-26589336, 91-11-26588707 Fax: 91-11-26588662 Email:icmrhqds[at]sansad[dot]nic[dot]in 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amrita Gaurav  All India institute of medical sciences, Rishikesh  department of Obstetrics and Gynecology All India Institute of Medical Sciences Virbhadra Road, Rishikesh Uttarakhand- 249 203, India
Dehradun
UTTARANCHAL 
8171025511

aamrity@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IECAIIMSRISHIKESH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N711||Chronic inflammatory disease of uterus,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Multimodal management   1.Standard of care 2.Psychological intervention program 3.PELVIC floor muscle therapy Duration of intervention 12 weeks  
Comparator Agent  Standard of Care   The Control group will receive traditional single mode approach (medical/surgical treatment). They will receive disease specific standard of care as per Standard Guidelines. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  47.00 Year(s)
Gender  Female 
Details  Surgery or MRI confirmed Endometriosis with moderate to severe chronic pelvic pain with NPRS more than 5 
 
ExclusionCriteria 
Details  (a)Not consenting for the study
(b)Serious physical pain diseases
(e.g., fibromyalgia, Crohn’s disease, Colitis Ulcerosa),
(b) Severe psychiatric diagnosis,
(c) Pregnancy or planned pregnancy during the study period,
(d) Estimated lack of mental or physical surplus to enter into a psychological treatment or cultural barriers.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Assessment of Pain severity using Numerical pain rating scale NPRS (0-10) in both Intervention and Control arm.
2. Assessment of Quality of life using WHOQOL-Bref questionnaire at in both Intervention and Control arm
 
1. At baseline , 6 and 12 weeks of the study in both Intervention and Control arm.
2. At baseline and 12 weeks of the study in both Intervention and Control arm
 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of Hematological & Biochemical parameters
 
At baseline & 12 weeks of the study & at 3 month follow up.
 
 
Target Sample Size   Total Sample Size="88"
Sample Size from India="88" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

RATIONALE OF THE STUDY: Endometriosis is a chronic, inammatory, estrogen-dependent disorder that is linked to pelvic pain, infertility, and a hampered quality of life. Typically, women with endometriosis are treated by a single physician. In this single-provider model of care, women frequently report lengthy diagnostic delays, unresolved pelvic pain, multiple laparoscopic surgeries, sequential consultations, and dissatisfaction with care overall. Multiple care team specialists with expertise in specic therapeutic areas treat patients with endometriosis and associated comorbidities in a coordinated, patient-centered manner. Novelty: The present study aims to study the eect of a multidisciplinary program of care on chronic pelvic pain and overall quality of life in women with endometriosis. There is a paucity of prospective randomized control trials. addressing this aspect of treatment, and there are no similar studies in the Indian population. OBJECTIVES- PRIMARY OBJECTIVES to study the eect of a multidisciplinary program of care on chronic pelvic pain and overall quality of life in women with endometriosis. . SECONDARY OBJECTIVES 1. To study the eect of a multidisciplinary program of care on hematological and biochemical parameters in women with endometriosis. 2. To perform next-generation sequencing analyses targeting novel variants of endometriosis in treatment-resistant patients. METHODS- Study design: open label A randomized controlled trial Study site- 1. Department of Obstetrics and Gynecology, AIIMS Rishikesh, in collaboration with the Department of Physical Medicine and Rehabilitation, the Department of Biochemistry, Intervention Arm: Multidisciplinary program of care along with standard of care treatment Control Arm: Standard of Care Treatment OUTCOMES - 1. Assessment of pain severity using the numerical pain rating scale NPRS (0–10) at 0, 6, and 12 weeks of the study in both the intervention and control arms. 2. Assessment of quality of life using the WHOQOL-Bref questionnaire at 0 and 12 weeks of the study in both the intervention and control arms 3. Assessment of hematological and biochemical parameters at 0 and 12 weeks of the study 

 
Close